These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

554 related articles for article (PubMed ID: 24880460)

  • 21. Developmental immunotoxicology (DIT): windows of vulnerability, immune dysfunction and safety assessment.
    Dietert RR
    J Immunotoxicol; 2008 Oct; 5(4):401-12. PubMed ID: 19404874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Zinc, infections and immunosenescence.
    Mocchegiani E; Giacconi R; Muzzioli M; Cipriano C
    Mech Ageing Dev; 2000 Dec; 121(1-3):21-35. PubMed ID: 11164457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The neonatal immune system: immunomodulation of infections in early life.
    Futata EA; Fusaro AE; de Brito CA; Sato MN
    Expert Rev Anti Infect Ther; 2012 Mar; 10(3):289-98. PubMed ID: 22397563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Skewed pattern of Toll-like receptor 4-mediated cytokine production in human neonatal blood: low LPS-induced IL-12p70 and high IL-10 persist throughout the first month of life.
    Belderbos ME; van Bleek GM; Levy O; Blanken MO; Houben ML; Schuijff L; Kimpen JL; Bont L
    Clin Immunol; 2009 Nov; 133(2):228-37. PubMed ID: 19648060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ageing and its possible impact on mucosal immune responses.
    Ogra PL
    Ageing Res Rev; 2010 Apr; 9(2):101-6. PubMed ID: 19664726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neonatal vaccine effectiveness and the role of adjuvants.
    Sakala IG; Eichinger KM; Petrovsky N
    Expert Rev Clin Immunol; 2019 Aug; 15(8):869-878. PubMed ID: 31293189
    [No Abstract]   [Full Text] [Related]  

  • 27. The science and medicine of human immunology.
    Pulendran B; Davis MM
    Science; 2020 Sep; 369(6511):. PubMed ID: 32973003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ontogeny and innate properties of neonatal dendritic cells.
    Sun CM; Fiette L; Tanguy M; Leclerc C; Lo-Man R
    Blood; 2003 Jul; 102(2):585-91. PubMed ID: 12663436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The ontogeny of the gut mucosal immune system and the susceptibility to infections in infants of developing countries.
    Prindull G; Ahmad M
    Eur J Pediatr; 1993 Oct; 152(10):786-92. PubMed ID: 8223777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Feasibility of human trials to assess developmental immunotoxicity, and some comparison with data on New World monkeys.
    Neubert RT; Webb JR; Neubert D
    Hum Exp Toxicol; 2002; 21(9-10):543-67. PubMed ID: 12458914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Challenges in infant immunity: implications for responses to infection and vaccines.
    PrabhuDas M; Adkins B; Gans H; King C; Levy O; Ramilo O; Siegrist CA
    Nat Immunol; 2011 Mar; 12(3):189-94. PubMed ID: 21321588
    [No Abstract]   [Full Text] [Related]  

  • 32. Development of immunity in early life.
    Goenka A; Kollmann TR
    J Infect; 2015 Jun; 71 Suppl 1():S112-20. PubMed ID: 25934325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Innovation in infectious disease therapies from immunology.
    O'Neil DA
    Drug Discov Today; 2021 Sep; 26(9):2090-2094. PubMed ID: 33798650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Murine [corrected] myeloid dendritic cell-dependent toll-like receptor immunity is preserved with aging.
    Tesar BM; Walker WE; Unternaehrer J; Joshi NS; Chandele A; Haynes L; Kaech S; Goldstein DR
    Aging Cell; 2006 Dec; 5(6):473-86. PubMed ID: 17129212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fetal and neonatal immunoincompetence.
    Vetro SW; Bellanti JA
    Fetal Ther; 1989; 4 Suppl 1():82-91. PubMed ID: 2487913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ontogeny of Toll-like receptor mediated cytokine responses of human blood mononuclear cells.
    Corbett NP; Blimkie D; Ho KC; Cai B; Sutherland DP; Kallos A; Crabtree J; Rein-Weston A; Lavoie PM; Turvey SE; Hawkins NR; Self SG; Wilson CB; Hajjar AM; Fortuno ES; Kollmann TR
    PLoS One; 2010 Nov; 5(11):e15041. PubMed ID: 21152080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activating Immunity to Fight a Foe - A New Path.
    Hotchkiss RS; Opal SM
    N Engl J Med; 2020 Mar; 382(13):1270-1272. PubMed ID: 32212525
    [No Abstract]   [Full Text] [Related]  

  • 38. Dendritic cell subsets in health and disease.
    Ueno H; Klechevsky E; Morita R; Aspord C; Cao T; Matsui T; Di Pucchio T; Connolly J; Fay JW; Pascual V; Palucka AK; Banchereau J
    Immunol Rev; 2007 Oct; 219():118-42. PubMed ID: 17850486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Measles and mumps vaccination as a model to investigate the developing immune system: passive and active immunity during the first year of life.
    Gans H; DeHovitz R; Forghani B; Beeler J; Maldonado Y; Arvin AM
    Vaccine; 2003 Jul; 21(24):3398-405. PubMed ID: 12850348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transient immunodepression.
    Verhoef J
    J Antimicrob Chemother; 1990 Nov; 26 Suppl C():23-9. PubMed ID: 2074249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.